Checkpoint Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Checkpoint Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2020 to Q2 2024.
  • Checkpoint Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 36.5M shares, a 133% increase year-over-year.
  • Checkpoint Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 18.7M shares, a 112% increase from 2022.
  • Checkpoint Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 8.84M shares, a 16.2% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 36.5M +20.8M +133% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 32.9M +21.2M +180% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 18.7M +9.91M +112% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 20M +11.1M +126% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 15.7M +6.95M +79.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 11.7M +3.24M +38.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 8.84M +1.23M +16.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 8.86M -69.7M -88.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 8.75M -66.7M -88.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 8.5M -61.8M -87.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 7.6M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 78.5M +22.1M +39.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 75.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 70.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 56.4M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.